Literature DB >> 32624246

The Roles of CD8+ T Cell Subsets in Antitumor Immunity.

Michael St Paul1, Pamela S Ohashi2.   

Abstract

Effector CD8+ T cells are typically thought to be a homogenous group of cytotoxic cells that produce interferon-(IFN) γ. However, recent findings have challenged this notion because multiple subsets of CD8+ T cells have been described, each with distinct effector functions and cytotoxic potential. These subsets, referred to as the Tc subsets, have also been detected in tumor microenvironments (TMEs), where they potentially influence the antitumor response and patient outcomes. In this review, we highlight the prevalence and roles of Tc subsets in the TME. We also discuss their therapeutic applications in the context of adoptive immunotherapy to treat cancer.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CD8(+) T cell; Tc subset; cytokines; immunotherapy

Mesh:

Year:  2020        PMID: 32624246     DOI: 10.1016/j.tcb.2020.06.003

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  55 in total

1.  Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity.

Authors:  Kebria Hezaveh; Rahul S Shinde; Andreas Klötgen; Marie Jo Halaby; Sara Lamorte; M Teresa Ciudad; Rene Quevedo; Luke Neufeld; Zhe Qi Liu; Robbie Jin; Barbara T Grünwald; Elisabeth G Foerster; Danica Chaharlangi; Mengdi Guo; Priya Makhijani; Xin Zhang; Trevor J Pugh; Devanand M Pinto; Ileana L Co; Alison P McGuigan; Gun Ho Jang; Rama Khokha; Pamela S Ohashi; Grainne M O'Kane; Steven Gallinger; William W Navarre; Heather Maughan; Dana J Philpott; David G Brooks; Tracy L McGaha
Journal:  Immunity       Date:  2022-02-08       Impact factor: 31.745

Review 2.  Dual Effect of Immune Cells within Tumour Microenvironment: Pro- and Anti-Tumour Effects and Their Triggers.

Authors:  Alicia Cristina Peña-Romero; Esteban Orenes-Piñero
Journal:  Cancers (Basel)       Date:  2022-03-25       Impact factor: 6.639

3.  Cyclin-Dependent Kinase Inhibitors Function as Potential Immune Regulators via Inducing Pyroptosis in Triple Negative Breast Cancer.

Authors:  Tao Xu; Zhen Wang; Jiahao Liu; Ge Wang; Dongchen Zhou; Yaying Du; Xingrui Li; Yu Xia; Qinglei Gao
Journal:  Front Oncol       Date:  2022-06-08       Impact factor: 5.738

4.  The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma.

Authors:  Till Sebastian Clauditz; Thorsten Rieckmann; Mara Borgmann; Agnes Oetting; Felix Meyer; Nikolaus Möckelmann; Conrad Droste; Clara Marie von Bargen; Christina Möller-Koop; Melanie Witt; Kerstin Borgmann; Kai Rothkamm; Christian Betz; Adrian Münscher
Journal:  J Cancer Res Clin Oncol       Date:  2022-08-08       Impact factor: 4.322

5.  Endometrial Cancer Suppresses CD8+ T Cell-Mediated Cytotoxicity in Postmenopausal Women.

Authors:  Mickey V Patel; Zheng Shen; Marta Rodriguez-Garcia; Edward J Usherwood; Laura J Tafe; Charles R Wira
Journal:  Front Immunol       Date:  2021-04-23       Impact factor: 7.561

6.  Immune evolution from preneoplasia to invasive lung adenocarcinomas and underlying molecular features.

Authors:  Hitoshi Dejima; Xin Hu; Runzhe Chen; Jiexin Zhang; Junya Fujimoto; Edwin R Parra; Cara Haymaker; Shawna M Hubert; Dzifa Duose; Luisa M Solis; Dan Su; Junya Fukuoka; Kazuhiro Tabata; Hoa H N Pham; Nicholas Mcgranahan; Baili Zhang; Jie Ye; Lisha Ying; Latasha Little; Curtis Gumbs; Chi-Wan Chow; Marcos Roberto Estecio; Myrna C B Godoy; Mara B Antonoff; Boris Sepesi; Harvey I Pass; Carmen Behrens; Jianhua Zhang; Ara A Vaporciyan; John V Heymach; Paul Scheet; J Jack Lee; Jia Wu; P Andrew Futreal; Alexandre Reuben; Humam Kadara; Ignacio I Wistuba; Jianjun Zhang
Journal:  Nat Commun       Date:  2021-05-11       Impact factor: 14.919

Review 7.  Hijacked Immune Cells in the Tumor Microenvironment: Molecular Mechanisms of Immunosuppression and Cues to Improve T Cell-Based Immunotherapy of Solid Tumors.

Authors:  Emre Balta; Guido H Wabnitz; Yvonne Samstag
Journal:  Int J Mol Sci       Date:  2021-05-27       Impact factor: 5.923

8.  Metabolic radiolabeling and in vivo PET imaging of cytotoxic T lymphocytes to guide combination adoptive cell transfer cancer therapy.

Authors:  Dehua Lu; Yanpu Wang; Ting Zhang; Feng Wang; Kui Li; Shixin Zhou; Hua Zhu; Zhi Yang; Zhaofei Liu
Journal:  J Nanobiotechnology       Date:  2021-06-10       Impact factor: 10.435

Review 9.  Tumor-infiltrating B cells as a favorable prognostic biomarker in breast cancer: a systematic review and meta-analysis.

Authors:  You Qin; Fei Peng; Lisha Ai; Shidai Mu; Yuting Li; Chensu Yang; Yu Hu
Journal:  Cancer Cell Int       Date:  2021-06-12       Impact factor: 5.722

10.  Tumor-infiltrating CD8+ T cell is prognostic and predicts adjuvant chemotherapy benefit in patients with limited-stage small cell esophageal carcinoma.

Authors:  Zhihui Zhang; Chaoqi Zhang; Guochao Zhang; Yuejun Luo; Liyan Xue; Qingpeng Zeng; Peng Wu; Lide Wang; Nan Sun; Jie He
Journal:  Clin Transl Med       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.